Latest Insider Transactions at Axogen, Inc. (AXGN)
This section provides a real-time view of insider transactions for Axogen, Inc. (AXGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Axogen, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Axogen, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 10
2022
|
Gregory Gene Freitag Director |
SELL
Open market or private sale
|
Direct |
8,886
-2.37%
|
$79,974
$9.7 P/Share
|
|
Aug 08
2022
|
Gregory Gene Freitag Director |
SELL
Open market or private sale
|
Direct |
13,046
-3.37%
|
$130,460
$10.37 P/Share
|
|
Aug 04
2022
|
Gregory Gene Freitag Director |
SELL
Open market or private sale
|
Direct |
24,000
-5.83%
|
$240,000
$10.64 P/Share
|
|
Jul 25
2022
|
Gregory Gene Freitag Director |
SELL
Payment of exercise price or tax liability
|
Direct |
30,296
-6.86%
|
$272,664
$9.26 P/Share
|
|
Jul 25
2022
|
Gregory Gene Freitag Director |
BUY
Exercise of conversion of derivative security
|
Direct |
83,000
+15.82%
|
$249,000
$3.38 P/Share
|
|
Jul 19
2022
|
Eric Sandberg Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,125
-6.54%
|
$9,000
$8.4 P/Share
|
|
Jul 19
2022
|
Angelo Scopelianos Chief R&D Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
657
-2.55%
|
$5,256
$8.4 P/Share
|
|
Jul 19
2022
|
Erick Wayne De Vinney Chief Innovation Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
405
-0.42%
|
$3,240
$8.4 P/Share
|
|
Jul 19
2022
|
Isabelle Billet Chief Strategy and BD Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
751
-3.0%
|
$6,008
$8.4 P/Share
|
|
Jul 19
2022
|
Michael Patrick Donovan VP Operations |
SELL
Sale (or disposition) back to the issuer
|
Direct |
657
-1.02%
|
$5,256
$8.4 P/Share
|
|
Jul 19
2022
|
Karen L. Zaderej CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,081
-0.92%
|
$72,648
$8.4 P/Share
|
|
Jul 19
2022
|
Peter J Mariani EVP & Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
947
-2.29%
|
$7,576
$8.4 P/Share
|
|
Jul 19
2022
|
Maria D. Martinez Chief Human Resources Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
657
-3.48%
|
$5,256
$8.4 P/Share
|
|
Jul 18
2022
|
Eric Sandberg Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,408
+20.39%
|
-
|
|
Jul 18
2022
|
Angelo Scopelianos Chief R&D Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,571
+10.15%
|
-
|
|
Jul 18
2022
|
Erick Wayne De Vinney Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,579
+1.65%
|
-
|
|
Jul 18
2022
|
Isabelle Billet Chief Strategy and BD Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,571
+9.55%
|
-
|
|
Jul 18
2022
|
Michael Patrick Donovan VP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2,571
+3.83%
|
-
|
|
Jul 18
2022
|
Karen L. Zaderej CEO |
BUY
Grant, award, or other acquisition
|
Direct |
22,076
+2.18%
|
-
|
|
Jul 18
2022
|
Peter J Mariani EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,710
+8.83%
|
-
|
|
Jul 18
2022
|
Maria D. Martinez Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,571
+12.0%
|
-
|
|
Jun 01
2022
|
Gregory Gene Freitag Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,036
+0.84%
|
-
|
|
Jun 01
2022
|
Mark Stephen Gold Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,036
+0.98%
|
-
|
|
Jun 01
2022
|
Guido J Neels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,036
+5.54%
|
-
|
|
Jun 01
2022
|
Amy Mc Bride Wendell Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,036
+7.95%
|
-
|
|
Jun 01
2022
|
Bradley Ottinger General Counsel and CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,775
-20.33%
|
-
|
|
Jun 01
2022
|
Bradley Ottinger General Counsel and CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,500
+45.49%
|
-
|
|
Jun 01
2022
|
Alan M Levine Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,036
+20.46%
|
-
|
|
Jun 01
2022
|
Paul Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,036
+50.0%
|
-
|
|
Mar 30
2022
|
Quentin S. Blackford Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,036
+10.0%
|
-
|
|
Mar 16
2022
|
Isabelle Billet Chief Strategy and BD Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,447
-10.1%
|
$17,129
$7.97 P/Share
|
|
Mar 16
2022
|
Isabelle Billet Chief Strategy and BD Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+25.98%
|
-
|
|
Mar 16
2022
|
Erick Wayne De Vinney Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,497
-1.59%
|
$10,479
$7.97 P/Share
|
|
Mar 16
2022
|
Erick Wayne De Vinney Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+6.0%
|
-
|
|
Mar 16
2022
|
Michael Patrick Donovan VP Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,512
-2.38%
|
$10,584
$7.97 P/Share
|
|
Mar 16
2022
|
Michael Patrick Donovan VP Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+8.64%
|
-
|
|
Mar 16
2022
|
Mark Louis Friedman VP Regulatory Affairs & Policy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,502
-5.81%
|
$10,514
$7.97 P/Share
|
|
Mar 16
2022
|
Mark Louis Friedman VP Regulatory Affairs & Policy |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+18.84%
|
-
|
|
Mar 16
2022
|
Peter J Mariani EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,769
-7.41%
|
$19,383
$7.97 P/Share
|
|
Mar 16
2022
|
Peter J Mariani EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+22.75%
|
-
|
|
Mar 16
2022
|
Bradley Ottinger General Counsel and CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
648
-17.41%
|
$4,536
$7.97 P/Share
|
|
Mar 16
2022
|
Bradley Ottinger General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
2,563
+40.79%
|
-
|
|
Mar 16
2022
|
Eric Sandberg Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,512
-10.57%
|
$10,584
$7.97 P/Share
|
|
Mar 16
2022
|
Eric Sandberg Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+29.54%
|
-
|
|
Mar 16
2022
|
Angelo Scopelianos Chief R&D Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,770
-12.07%
|
$19,390
$7.97 P/Share
|
|
Mar 16
2022
|
Angelo Scopelianos Chief R&D Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+32.4%
|
-
|
|
Mar 16
2022
|
Karen L. Zaderej CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,950
+2.62%
|
-
|
|
Mar 16
2022
|
Maria D. Martinez Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,239
-16.59%
|
$22,673
$7.97 P/Share
|
|
Mar 16
2022
|
Maria D. Martinez Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,866
+29.35%
|
-
|
|
Feb 22
2022
|
Michael Patrick Donovan VP Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+12.01%
|
$75,000
$5.27 P/Share
|